Experience real-time quotes &

news with the most powerful

iPhone application for investors.

Get the FREE DailyFinance iPhone application



  • CEPHEID Analyst Recommendations

  • Analyst Consensus: CPHD

    First Call Consensus Recommendation

    • Strong Buy1
    • Buy2
    • Hold3
    • Sell4
    • Strong Sell5
    Mean Analyst Consensus Recommendation Analysts Reporting
    Current Recommendation 2.545 Hold 11
    30 Days Ago 2.545 Hold 11
    60 Days Ago 2.455 Buy 11
    90 Days Ago 2.455 Buy 11
    120 Days Ago 2.273 Buy 11

  • Analyst Ratings: CPHD

    Brokerage Firm Previous Rating Current Rating Change Date Price Target
    Needham Hold Buy 10/14/2009 17.00
    Robert W. Baird Outperform Neutral 09/25/2009 —
    Avondale — Mkt Perform 05/29/2009 12.00
    UBS — Neutral 01/14/2009 8.00
    Caris & Company Buy Above Average 01/14/2009 16.00
    Leerink Swann Outperform Mkt Perform 01/13/2009 —
    William Blair Outperform Mkt Perform 01/12/2009 —
    Needham Buy Hold 01/09/2009 —
    Avondale — Mkt Perform 12/19/2008 —
    Robert W. Baird — Outperform 12/15/2008 14.00
    Needham — Buy 11/20/2008 21.00
    Leerink Swann — Outperform 11/12/2008 —
    Piper Jaffray Buy Neutral 09/10/2008 —
    UBS Buy Neutral 08/14/2008 23.00
    UBS — Buy 07/28/2008 23.00
    Caris & Company — Buy 07/25/2008 27.00
    RBC Capital Mkts Outperform Underperform 07/25/2008 —
    RBC Capital Mkts — Outperform 07/15/2008 34.00
    UBS Neutral Buy 04/17/2008 —
    Caris & Company Above Average Buy 03/11/2008 34.00
    Caris & Company — Above Average 02/29/2008 34.00
    Piper Jaffray Neutral Buy 11/28/2007 —
    Caris & Company — Above Average 11/02/2007 30.00
    Piper Jaffray — Market Perform 10/11/2007 —
    Caris & Company — Above Average 10/03/2007 25.00
    UBS Buy Neutral 09/05/2007 —
    First Analysis Sec — Equal-Weight 08/28/2007 —
    Caris & Company Buy Above Average 08/23/2007 21.00
    UBS — Buy 08/08/2007 19.00
    UBS — Buy 07/05/2007 18.00
    Next